|
526443
|
Artificial Elect
|
12-Jun-2025
|
Inter alia, to consider and approve the following matters: 1) Proposal for raising of funds by the Company, by way of inter alia, issue of equity shares or any other equity linked instruments or securities including convertible preference shares/ fully or partly convertible debentures or by way of a composite issue of nonconvertible debentures and warrants entitling the warrant holder(s) to apply for equity shares, or any other eligible securities through inter alia, a private placement (including one or more qualified institutions placements) or further public issue of equity/ debt securities, preferential issue or a rights issue or through any other permissible mode under applicable laws and/ or combination thereof, as may be considered appropriate, subject to such statutory/regulatory/other approvals as may be required, including the approval of the members, to seek their consent for such fund raising and to approve ancillary actions for such fund raising. Pursuant to Clause 4 of Schedule B of Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 as amended and trading restrictions placed by the Company's Code of Practices, Procedure and Conduct to Regulate, Monitor and Report Trading by Insiders (`the Code'), we hereby inform that the Trading Window for purchasing, selling or dealing in the Equity Shares of the Company, will remain closed for all Directors, Promoters, Designated Persons and Insiders and their immediate relatives will remain closed from Thursday, 5th June, 2025 till 48 hours from the conclusion of the meeting. 2) To fix the day, date and time of 33rd Annual General Meeting ("AGM") of the financial
|
|
535467
|
Ashapura Inti.
|
12-Jun-2025
|
Ashapura Intimates Fashion Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/06/2025 inter alia to consider and approve consider and approve:
1) Unaudited standalone financial results for the quarter ended June 30 2021
2) Unaudited standalone financial results for the quarter ended September 30 2021
3) Unaudited Standalone financial results for the quarter ended December 31 2021
4) Audited standalone financial results for the quarter and year ended March 31 2022
5) Unaudited standalone financial results for the quarter ended June 30 2022
6) Unaudited standalone financial results for the quarter ended September 30 2022
7) Unaudited Standalone financial results for the quarter ended December 31 2022
8) Audited standalone financial results for the quarter and year ended March 31 2023
|
|
532483
|
Canara Bank
|
12-Jun-2025
|
Inter-alia, to consider and approve Capital Raising Plan of the Bank for FY 2025-26 subject to necessary approvals/ permissions.
The Board Meeting to be held on 20/06/2025 has been revised to 12/06/2025 The Board Meeting to be held on 20/06/2025 has been revised to 12/06/2025 to consider and approve Capital Raising Plan of the Bank for FY 2025-26, subject to necessary approvals/ permissions.
(As per BSE Announcement Dated on 05/06/2025)
|
|
511505
|
Capital Trust
|
12-Jun-2025
|
Capital Trust Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/06/2025 inter alia to consider and approve Consider discuss and approve the terms and conditions of the proposed Rights Issue including the issue
price rights entitlement ratio record date issue opening and closing dates and other related matters;
Consider and approve any other matter incidental and connected thereto.
To consider Fund Raising
(As Per NSE Announcement Dated On : 09.06.2025)
|
|
532324
|
Cinevista
|
12-Jun-2025
|
Cinevista Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/06/2025 inter alia to consider and approve The Carpet Area Sanctions received for Tower A and B in the Project titled Antares which falls under the Joint Development Agreement entered into with K Raheja Corp Real Estate Pvt Ltd
|
|
511543
|
GSB Finance
|
12-Jun-2025
|
GSB Finance Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/06/2025 inter alia to consider and approve Pursuant to Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulation 2015 a meeting of Board of Directors of the Company is scheduled to be held on Thursday 12th June2025 interalia for constitution of RIsk Management Committee as per Regulation 39-Master Direction- Reserve Bank of India (Non-Banking Financial Company-Scale Based Regualtion) DIrections 2023
|
|
512405
|
I Power Solution
|
12-Jun-2025
|
I-Power Solutions India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/06/2025 inter alia to consider and approve (1) Allotment of 1600000 equity shares on preferential basis to certain identified non promoter persons.
(2) Any other business with the permission of the chair.
|
|
526445
|
Indrayani Biotec
|
12-Jun-2025
|
Indrayani Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/06/2025 inter alia to consider and approve audited financial results (standalone and consolidated) for quarter and year ended 31st March 2025
The Company, vide its announcement dated 27th May 2025, informed that the Board meeting for approving the said results would be convened by 9th June 2025, after the due date, since the consolidation of results from our subsidiaries combined along with completion of internal and external audit processes of the company are taking more time than estimated to complete the preparation of the results.
However, the Company understands that the finalisation of audited financial results (standalone and consolidated) for the quarter and year ended 31st March 2025 requires some more time and hence the Board meeting for approval of said results planned for today is adjourned to 12th June 2025.
(As per BSE Announcement Dated on 09/06/2025)
|
|
526423
|
Kriti Industries
|
12-Jun-2025
|
Kriti Industries India Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/06/2025 inter alia to consider and approve 1. To consider and approve conversion of warrants into the equity shares of the Company subject to depositing the balance outstanding amount for conversion of warrants into the equity shares of the Company;
2. And other general business as may be transacted by the Board.
|
|
531996
|
Odyssey Corpn.
|
12-Jun-2025
|
Odyssey Corporation Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/06/2025 inter alia to consider and approve Postal Ballot Notice with Explanatory Statements
|